Brent Hatzis-Schoch is SEE REMARKS at Black Diamond Therapeutics, Inc. (BDTX). They have made 11 open-market trades across 2 companies since 2017, most recently 2025-01-30.
CIK 0001637054
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $107K since 2017, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BDTX | SELL | 2021-05-12 | 2021-05-13 | $27.60 | $183K | -50.0% | -51.8% | -64.4% |
| BDTX | SELL | 2021-04-12 | 2021-04-13 | $25.00 | $102K | +4.8% | +4.3% | -56.2% |
| BDTX | SELL | 2021-03-12 | 2021-03-16 | $26.36 | $215K | -10.0% | -0.8% | -49.6% |
| BDTX | SELL | 2021-02-12 | 2021-02-12 | $27.21 | $214K | +4.8% | -3.4% | -1.7% |
| BDTX | SELL | 2021-01-12 | 2021-01-14 | $33.10 | $506K | -18.2% | -7.1% | -14.4% |
| BDTX | SELL | 2020-12-14 | 2020-12-16 | $34.95 | $285K | -4.4% | -21.9% | -25.4% |
| BDTX | SELL | 2020-11-12 | 2020-11-13 | $33.96 | $268K | +0.2% | +2.8% | -16.4% |
| BDTX | SELL | 2020-10-12 | 2020-10-14 | $32.65 | $257K | -1.1% | +1.3% | -9.3% |
| BDTX | SELL | 2020-09-14 | 2020-09-16 | $30.93 | $209K | -2.0% | +15.1% | +17.5% |
| BDTX | BUY | 2020-02-03 | 2020-02-05 | $19.00 | $57K | -4.7% | -21.6% | +2.5% |
| RDUS | BUY | 2017-11-10 | 2017-11-13 | $28.09 | $50K | +3.6% | +7.3% | +32.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.